MedTrace Logo

Cytokine Adsorption in Sepsis and Acute Kidney Injury

NCT02588794 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 124

Last updated 2015-10-28

No results posted yet for this study

Summary

Aim of the study is to reduce the incidence of RIFLE stadium L and E after acute kidney injury in patients with severe sepsis/septic shock

Conditions

  • Renal Insufficiency or Renal Failure &or End-stage Renal Disease

Interventions

DEVICE

CytoSorb 300 ml device (3804606CE01)

additional cytokine adsorber

Sponsors & Collaborators

  • Technical University of Munich

    lead OTHER

Principal Investigators

  • Kochs Eberhard, Chairman · Department of Anaesthsiology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2017-08-31
Completion
2017-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02588794 on ClinicalTrials.gov